Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?

By M. Duffy. Clinical Chemistry, 2001

806 citations recorded by the source corpus.

Subfields: Hepatology, Oncology, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/425728fadcea61776ea78a6e3ecbd2698e2a1f5d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Hepatology

1. Richard Hargreaves
2. Richard Frank

In Oncology

1. Richard Hargreaves
2. Richard Frank

In Radiology, Nuclear Medicine and Imaging

1. Richard Hargreaves
2. Richard Frank

Citations in the corpus

• Clinical biomarkers in drug discovery and development (2003, background): “Biochemical biomarkers have long contributed to the assessment of risk and benefits in cancer, and routine clinical assays are available for such markers as prostate-specific antigen and carcinoembryonic antige”
• Protein Glycosylation in Cancer (2015, background): “Serial CEA measurements can detect recurrent colorectal cancer with a sensitivity of ∼80% and a specificity of ∼70% (111).”